139 results on '"Aljama, Mohammed A."'
Search Results
2. Risk of cancer-specific death among octogenarians with multiple myeloma: A population-based analysis
3. Incidence of second primary malignancies in patients with multiple myeloma receiving anti-CD38 monoclonal antibodies: A systematic review and meta-analysis
4. Are we maintaining minimal residual disease in myeloma?
5. Prevalence of geriatric impairments and frailty categorization among real-world patients with multiple myeloma: a prospective cohort study (MFRAIL)
6. Comparison of different techniques to identify cardiac involvement in immunoglobulin light chain (AL) amyloidosis
7. Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma
8. Prognostic Significance of Stringent Complete Response after Stem Cell Transplantation in Immunoglobulin Light Chain Amyloidosis
9. Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation
10. Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation
11. Venetoclax for the treatment of translocation (11;14) AL amyloidosis
12. The role of bone marrow biopsy in patients with plasma cell disorders: should all patients with a monoclonal protein be biopsied?
13. Bortezomib, lenalidomide, and dexamethasone (VRd) followed by autologous stem cell transplant for multiple myeloma
14. Next Generation BTK Inhibitor Acalabrutinib with Bendamustine-Rituximab in First Line Waldenstrom's Macroglobulinemia: The Brawm Study
15. Post Autologous Stem Cell Transplant Maintenance in Patients with Newly Diagnosed Multiple Myeloma: A Network Meta-Analysis
16. Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high‐risk cytogenetics: A meta‐analysis of randomized controlled trials
17. Checkpoint Inhibitors in Multiple Myeloma: Intriguing Potential and Unfulfilled Promises
18. Monoclonal Immunoglobulin Deposition Disease - a Review of Current and Emerging Data
19. Efficacy of Maintenance Therapies By Prognostic Subgroups in Post-Transplant Newly Diagnosed Multiple Myeloma Patients: A Systematic Review and Network Meta-Analysis
20. Indolent Lymphoma: High CR and VGPR Rate with Fixed Duration Bendamustine, Rituximab and Acalabrutinib in Waldenstroms Macroglobulinaemia (BRAWM)
21. Treatment Patterns and Healthcare Resource Utilization Among Patients with Triple Class Exposed Multiple Myeloma: A Population-Based Cohort Study
22. Choosing optimal therapy for relapsed refractory multiple myeloma: A systematic review and network meta-analysis.
23. The Impact of COVID-19 on Cyber Security
24. Novel Single Panel Method for Minimal Residual Disease Detection for Plasma Cells By Flow Cytometry
25. Autologous Stem Cell Transplant for Immunoglobulin Light Chain Amyloidosis Patients Aged 70 to 75
26. Autologous stem cell transplant for AL amyloidosis patients aged 70 to 75
27. Venetoclax For The Treatment of Translocation AL Amyloidosis
28. The role of bone marrow biopsy in patients with plasma cell disorders; should all patients with a monoclonal protein be biopsied?
29. The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors
30. The Human Microbiota in Multiple Myeloma and Proteasome Inhibitors.
31. Therapy for relapsed multiple myeloma
32. Bortezomib, Lenalidomide and Dexamethasone (VRD) Followed By Autologous Stem Cell Transplant for Newly Diagnosed Multiple Myeloma; The Mayo Clinic Experience
33. Three Decades of Autologous Stem Cell Transplantation for Myeloma; Trends in Early Mortality and Survival
34. Comparison of Different Techniques to Identify Cardiac Involvement in Immunoglobulin Light Chain Amyloidosis
35. T Cell Large Granular Lymphocytic Leukemia and Co-Existing Plasma Cell Disorders
36. Safety and efficacy of propylene glycol-free melphalan as conditioning in patients with AL amyloidosis undergoing stem cell transplantation
37. Utility and prognostic value of18F-FDG positron emission tomography-computed tomography scans in patients with newly diagnosed multiple myeloma
38. T-cell large granular lymphocytic leukemia and plasma cell disorders
39. Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
40. Utility and prognostic value of 18F-FDG PET/CT scan in patients with newly diagnosed multiple myeloma.
41. Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time
42. Plasma cell proliferative index predicts outcome in immunoglobulin light chain amyloidosis treated with stem cell transplantation
43. Utility and prognostic value of 18F‐FDG positron emission tomography‐computed tomography scans in patients with newly diagnosed multiple myeloma.
44. Plasma cell proliferative index post-transplant is a powerful predictor of prognosis in myeloma patients failing to achieve a complete response
45. Strongyloides stercoralis hyperinfection in a post-renal transplant patient
46. Incidence of second primary malignancies (SPMs) in patients with multiple myeloma (MM) receiving anti-CD38 monoclonal antibodies (mAbs): A systematic review and meta-analysis.
47. Association of dose escalation of octreotide long‐acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors
48. Strongyloides stercoralis hyperinfection in a post-renal transplant patient
49. Effect of dose intensification (DI) of octreotide-LAR (O-LAR) among symptomatic patients with neuroendocrine tumors (NETs).
50. Thromboembolism in inflammatory bowel diseases: a report from Saudi Arabia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.